nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ABCB1—Lisinopril—systemic scleroderma	0.139	0.267	CbGbCtD
Acebutolol—ABCB1—Captopril—systemic scleroderma	0.104	0.2	CbGbCtD
Acebutolol—CYP2D6—Captopril—systemic scleroderma	0.0983	0.188	CbGbCtD
Acebutolol—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0822	0.157	CbGbCtD
Acebutolol—ABCB1—Prednisone—systemic scleroderma	0.0657	0.126	CbGbCtD
Acebutolol—ABCB1—Methotrexate—systemic scleroderma	0.033	0.063	CbGbCtD
Acebutolol—Dyspepsia—Leflunomide—systemic scleroderma	0.000621	0.0013	CcSEcCtD
Acebutolol—Vomiting—Mometasone—systemic scleroderma	0.00062	0.0013	CcSEcCtD
Acebutolol—Feeling abnormal—Azathioprine—systemic scleroderma	0.000616	0.00129	CcSEcCtD
Acebutolol—Rash—Mometasone—systemic scleroderma	0.000614	0.00129	CcSEcCtD
Acebutolol—Asthenia—Captopril—systemic scleroderma	0.000614	0.00129	CcSEcCtD
Acebutolol—Dermatitis—Mometasone—systemic scleroderma	0.000614	0.00129	CcSEcCtD
Acebutolol—Decreased appetite—Leflunomide—systemic scleroderma	0.000613	0.00129	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000613	0.00129	CcSEcCtD
Acebutolol—Confusional state—Lisinopril—systemic scleroderma	0.000611	0.00128	CcSEcCtD
Acebutolol—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000611	0.00128	CcSEcCtD
Acebutolol—Headache—Mometasone—systemic scleroderma	0.000611	0.00128	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000609	0.00128	CcSEcCtD
Acebutolol—Insomnia—Mycophenolic acid—systemic scleroderma	0.000609	0.00128	CcSEcCtD
Acebutolol—Fatigue—Leflunomide—systemic scleroderma	0.000608	0.00127	CcSEcCtD
Acebutolol—Oedema—Lisinopril—systemic scleroderma	0.000606	0.00127	CcSEcCtD
Acebutolol—Pruritus—Captopril—systemic scleroderma	0.000606	0.00127	CcSEcCtD
Acebutolol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000604	0.00127	CcSEcCtD
Acebutolol—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000604	0.00127	CcSEcCtD
Acebutolol—Constipation—Leflunomide—systemic scleroderma	0.000603	0.00126	CcSEcCtD
Acebutolol—Pain—Leflunomide—systemic scleroderma	0.000603	0.00126	CcSEcCtD
Acebutolol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.0006	0.00126	CcSEcCtD
Acebutolol—Somnolence—Mycophenolic acid—systemic scleroderma	0.000598	0.00125	CcSEcCtD
Acebutolol—Shock—Lisinopril—systemic scleroderma	0.000596	0.00125	CcSEcCtD
Acebutolol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000592	0.00124	CcSEcCtD
Acebutolol—Abdominal pain—Azathioprine—systemic scleroderma	0.000591	0.00124	CcSEcCtD
Acebutolol—Body temperature increased—Azathioprine—systemic scleroderma	0.000591	0.00124	CcSEcCtD
Acebutolol—Skin disorder—Lisinopril—systemic scleroderma	0.000589	0.00123	CcSEcCtD
Acebutolol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000587	0.00123	CcSEcCtD
Acebutolol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000586	0.00123	CcSEcCtD
Acebutolol—Diarrhoea—Captopril—systemic scleroderma	0.000586	0.00123	CcSEcCtD
Acebutolol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000585	0.00123	CcSEcCtD
Acebutolol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000585	0.00123	CcSEcCtD
Acebutolol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000584	0.00122	CcSEcCtD
Acebutolol—Erectile dysfunction—Prednisone—systemic scleroderma	0.000583	0.00122	CcSEcCtD
Acebutolol—Feeling abnormal—Leflunomide—systemic scleroderma	0.000581	0.00122	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000581	0.00122	CcSEcCtD
Acebutolol—Fatigue—Mycophenolic acid—systemic scleroderma	0.00058	0.00122	CcSEcCtD
Acebutolol—Mood swings—Methotrexate—systemic scleroderma	0.00058	0.00122	CcSEcCtD
Acebutolol—Nausea—Mometasone—systemic scleroderma	0.000579	0.00121	CcSEcCtD
Acebutolol—Anorexia—Lisinopril—systemic scleroderma	0.000578	0.00121	CcSEcCtD
Acebutolol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000577	0.00121	CcSEcCtD
Acebutolol—Weight increased—Prednisone—systemic scleroderma	0.000576	0.00121	CcSEcCtD
Acebutolol—Pain—Mycophenolic acid—systemic scleroderma	0.000576	0.00121	CcSEcCtD
Acebutolol—Constipation—Mycophenolic acid—systemic scleroderma	0.000576	0.00121	CcSEcCtD
Acebutolol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000575	0.00121	CcSEcCtD
Acebutolol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000572	0.0012	CcSEcCtD
Acebutolol—Cough—Mycophenolate mofetil—systemic scleroderma	0.000568	0.00119	CcSEcCtD
Acebutolol—Hypotension—Lisinopril—systemic scleroderma	0.000566	0.00119	CcSEcCtD
Acebutolol—Dizziness—Captopril—systemic scleroderma	0.000566	0.00119	CcSEcCtD
Acebutolol—Depression—Prednisone—systemic scleroderma	0.000563	0.00118	CcSEcCtD
Acebutolol—Urticaria—Leflunomide—systemic scleroderma	0.00056	0.00117	CcSEcCtD
Acebutolol—Body temperature increased—Leflunomide—systemic scleroderma	0.000558	0.00117	CcSEcCtD
Acebutolol—Abdominal pain—Leflunomide—systemic scleroderma	0.000558	0.00117	CcSEcCtD
Acebutolol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000555	0.00116	CcSEcCtD
Acebutolol—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000554	0.00116	CcSEcCtD
Acebutolol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000554	0.00116	CcSEcCtD
Acebutolol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000554	0.00116	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000552	0.00116	CcSEcCtD
Acebutolol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000552	0.00116	CcSEcCtD
Acebutolol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00055	0.00115	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00055	0.00115	CcSEcCtD
Acebutolol—Insomnia—Lisinopril—systemic scleroderma	0.000548	0.00115	CcSEcCtD
Acebutolol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000547	0.00115	CcSEcCtD
Acebutolol—Paraesthesia—Lisinopril—systemic scleroderma	0.000544	0.00114	CcSEcCtD
Acebutolol—Vomiting—Captopril—systemic scleroderma	0.000544	0.00114	CcSEcCtD
Acebutolol—Dyspnoea—Lisinopril—systemic scleroderma	0.00054	0.00113	CcSEcCtD
Acebutolol—Rash—Captopril—systemic scleroderma	0.00054	0.00113	CcSEcCtD
Acebutolol—Dermatitis—Captopril—systemic scleroderma	0.000539	0.00113	CcSEcCtD
Acebutolol—Somnolence—Lisinopril—systemic scleroderma	0.000539	0.00113	CcSEcCtD
Acebutolol—Headache—Captopril—systemic scleroderma	0.000536	0.00112	CcSEcCtD
Acebutolol—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000536	0.00112	CcSEcCtD
Acebutolol—Dyspepsia—Lisinopril—systemic scleroderma	0.000534	0.00112	CcSEcCtD
Acebutolol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000532	0.00112	CcSEcCtD
Acebutolol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000532	0.00112	CcSEcCtD
Acebutolol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000531	0.00111	CcSEcCtD
Acebutolol—Decreased appetite—Lisinopril—systemic scleroderma	0.000527	0.0011	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000523	0.0011	CcSEcCtD
Acebutolol—Fatigue—Lisinopril—systemic scleroderma	0.000523	0.0011	CcSEcCtD
Acebutolol—Shock—Mycophenolate mofetil—systemic scleroderma	0.000523	0.0011	CcSEcCtD
Acebutolol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000521	0.00109	CcSEcCtD
Acebutolol—Pain—Lisinopril—systemic scleroderma	0.000518	0.00109	CcSEcCtD
Acebutolol—Constipation—Lisinopril—systemic scleroderma	0.000518	0.00109	CcSEcCtD
Acebutolol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000516	0.00108	CcSEcCtD
Acebutolol—Bradycardia—Prednisone—systemic scleroderma	0.000516	0.00108	CcSEcCtD
Acebutolol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000513	0.00108	CcSEcCtD
Acebutolol—Diarrhoea—Azathioprine—systemic scleroderma	0.000511	0.00107	CcSEcCtD
Acebutolol—Nausea—Captopril—systemic scleroderma	0.000508	0.00107	CcSEcCtD
Acebutolol—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000506	0.00106	CcSEcCtD
Acebutolol—Asthenia—Leflunomide—systemic scleroderma	0.000506	0.00106	CcSEcCtD
Acebutolol—Hallucination—Prednisone—systemic scleroderma	0.000504	0.00106	CcSEcCtD
Acebutolol—Feeling abnormal—Lisinopril—systemic scleroderma	0.0005	0.00105	CcSEcCtD
Acebutolol—Pruritus—Leflunomide—systemic scleroderma	0.000499	0.00105	CcSEcCtD
Acebutolol—Connective tissue disorder—Prednisone—systemic scleroderma	0.000498	0.00104	CcSEcCtD
Acebutolol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000496	0.00104	CcSEcCtD
Acebutolol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000496	0.00104	CcSEcCtD
Acebutolol—Dysuria—Methotrexate—systemic scleroderma	0.000495	0.00104	CcSEcCtD
Acebutolol—Dizziness—Azathioprine—systemic scleroderma	0.000494	0.00104	CcSEcCtD
Acebutolol—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000487	0.00102	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000484	0.00101	CcSEcCtD
Acebutolol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000483	0.00101	CcSEcCtD
Acebutolol—Diarrhoea—Leflunomide—systemic scleroderma	0.000483	0.00101	CcSEcCtD
Acebutolol—Urticaria—Lisinopril—systemic scleroderma	0.000482	0.00101	CcSEcCtD
Acebutolol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00048	0.00101	CcSEcCtD
Acebutolol—Body temperature increased—Lisinopril—systemic scleroderma	0.000479	0.001	CcSEcCtD
Acebutolol—Abdominal pain—Lisinopril—systemic scleroderma	0.000479	0.001	CcSEcCtD
Acebutolol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000477	0.001	CcSEcCtD
Acebutolol—Pruritus—Mycophenolic acid—systemic scleroderma	0.000476	0.000998	CcSEcCtD
Acebutolol—Vomiting—Azathioprine—systemic scleroderma	0.000475	0.000996	CcSEcCtD
Acebutolol—Pneumonia—Methotrexate—systemic scleroderma	0.000475	0.000995	CcSEcCtD
Acebutolol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000474	0.000993	CcSEcCtD
Acebutolol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000472	0.00099	CcSEcCtD
Acebutolol—Drowsiness—Methotrexate—systemic scleroderma	0.000472	0.000989	CcSEcCtD
Acebutolol—Rash—Azathioprine—systemic scleroderma	0.000471	0.000987	CcSEcCtD
Acebutolol—Dermatitis—Azathioprine—systemic scleroderma	0.000471	0.000986	CcSEcCtD
Acebutolol—Depression—Methotrexate—systemic scleroderma	0.00047	0.000986	CcSEcCtD
Acebutolol—Flushing—Prednisone—systemic scleroderma	0.00047	0.000986	CcSEcCtD
Acebutolol—Headache—Azathioprine—systemic scleroderma	0.000468	0.000981	CcSEcCtD
Acebutolol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000468	0.00098	CcSEcCtD
Acebutolol—Dizziness—Leflunomide—systemic scleroderma	0.000467	0.000978	CcSEcCtD
Acebutolol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000462	0.000968	CcSEcCtD
Acebutolol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00046	0.000965	CcSEcCtD
Acebutolol—Angiopathy—Prednisone—systemic scleroderma	0.00046	0.000964	CcSEcCtD
Acebutolol—Conjunctivitis—Methotrexate—systemic scleroderma	0.000459	0.000961	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000459	0.000961	CcSEcCtD
Acebutolol—Pain—Mycophenolate mofetil—systemic scleroderma	0.000454	0.000952	CcSEcCtD
Acebutolol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000454	0.000952	CcSEcCtD
Acebutolol—Sweating—Methotrexate—systemic scleroderma	0.000452	0.000948	CcSEcCtD
Acebutolol—Vomiting—Leflunomide—systemic scleroderma	0.000449	0.00094	CcSEcCtD
Acebutolol—Alopecia—Prednisone—systemic scleroderma	0.000448	0.000939	CcSEcCtD
Acebutolol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000445	0.000933	CcSEcCtD
Acebutolol—Rash—Leflunomide—systemic scleroderma	0.000445	0.000932	CcSEcCtD
Acebutolol—Dermatitis—Leflunomide—systemic scleroderma	0.000444	0.000932	CcSEcCtD
Acebutolol—Nausea—Azathioprine—systemic scleroderma	0.000444	0.00093	CcSEcCtD
Acebutolol—Headache—Leflunomide—systemic scleroderma	0.000442	0.000926	CcSEcCtD
Acebutolol—Agranulocytosis—Methotrexate—systemic scleroderma	0.00044	0.000923	CcSEcCtD
Acebutolol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000438	0.000917	CcSEcCtD
Acebutolol—Asthenia—Lisinopril—systemic scleroderma	0.000435	0.000912	CcSEcCtD
Acebutolol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000434	0.00091	CcSEcCtD
Acebutolol—Pruritus—Lisinopril—systemic scleroderma	0.000429	0.000899	CcSEcCtD
Acebutolol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000428	0.000897	CcSEcCtD
Acebutolol—Rash—Mycophenolic acid—systemic scleroderma	0.000424	0.00089	CcSEcCtD
Acebutolol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000424	0.000889	CcSEcCtD
Acebutolol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000422	0.000884	CcSEcCtD
Acebutolol—Headache—Mycophenolic acid—systemic scleroderma	0.000422	0.000884	CcSEcCtD
Acebutolol—Pharyngitis—Methotrexate—systemic scleroderma	0.00042	0.000881	CcSEcCtD
Acebutolol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00042	0.00088	CcSEcCtD
Acebutolol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00042	0.00088	CcSEcCtD
Acebutolol—Nausea—Leflunomide—systemic scleroderma	0.000419	0.000878	CcSEcCtD
Acebutolol—Vision blurred—Prednisone—systemic scleroderma	0.000416	0.000871	CcSEcCtD
Acebutolol—Diarrhoea—Lisinopril—systemic scleroderma	0.000415	0.000869	CcSEcCtD
Acebutolol—Ill-defined disorder—Prednisone—systemic scleroderma	0.000409	0.000858	CcSEcCtD
Acebutolol—Visual impairment—Methotrexate—systemic scleroderma	0.000408	0.000856	CcSEcCtD
Acebutolol—Dizziness—Lisinopril—systemic scleroderma	0.000401	0.00084	CcSEcCtD
Acebutolol—Nausea—Mycophenolic acid—systemic scleroderma	0.0004	0.000838	CcSEcCtD
Acebutolol—Malaise—Prednisone—systemic scleroderma	0.000398	0.000834	CcSEcCtD
Acebutolol—Vertigo—Prednisone—systemic scleroderma	0.000396	0.000831	CcSEcCtD
Acebutolol—Syncope—Prednisone—systemic scleroderma	0.000396	0.000829	CcSEcCtD
Acebutolol—Tinnitus—Methotrexate—systemic scleroderma	0.000395	0.000828	CcSEcCtD
Acebutolol—Loss of consciousness—Prednisone—systemic scleroderma	0.000388	0.000813	CcSEcCtD
Acebutolol—Vomiting—Lisinopril—systemic scleroderma	0.000385	0.000808	CcSEcCtD
Acebutolol—Angiopathy—Methotrexate—systemic scleroderma	0.000384	0.000805	CcSEcCtD
Acebutolol—Rash—Lisinopril—systemic scleroderma	0.000382	0.000801	CcSEcCtD
Acebutolol—Dermatitis—Lisinopril—systemic scleroderma	0.000382	0.0008	CcSEcCtD
Acebutolol—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000382	0.0008	CcSEcCtD
Acebutolol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000381	0.000799	CcSEcCtD
Acebutolol—Chills—Methotrexate—systemic scleroderma	0.00038	0.000797	CcSEcCtD
Acebutolol—Headache—Lisinopril—systemic scleroderma	0.00038	0.000796	CcSEcCtD
Acebutolol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000376	0.000788	CcSEcCtD
Acebutolol—Arthralgia—Prednisone—systemic scleroderma	0.000376	0.000787	CcSEcCtD
Acebutolol—Myalgia—Prednisone—systemic scleroderma	0.000376	0.000787	CcSEcCtD
Acebutolol—Anxiety—Prednisone—systemic scleroderma	0.000374	0.000785	CcSEcCtD
Acebutolol—Alopecia—Methotrexate—systemic scleroderma	0.000374	0.000784	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000373	0.000782	CcSEcCtD
Acebutolol—Discomfort—Prednisone—systemic scleroderma	0.000371	0.000778	CcSEcCtD
Acebutolol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000363	0.000762	CcSEcCtD
Acebutolol—Nausea—Lisinopril—systemic scleroderma	0.00036	0.000755	CcSEcCtD
Acebutolol—Oedema—Prednisone—systemic scleroderma	0.00036	0.000755	CcSEcCtD
Acebutolol—Back pain—Methotrexate—systemic scleroderma	0.000357	0.000748	CcSEcCtD
Acebutolol—Shock—Prednisone—systemic scleroderma	0.000354	0.000743	CcSEcCtD
Acebutolol—Nervous system disorder—Prednisone—systemic scleroderma	0.000353	0.00074	CcSEcCtD
Acebutolol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000351	0.000736	CcSEcCtD
Acebutolol—Skin disorder—Prednisone—systemic scleroderma	0.00035	0.000733	CcSEcCtD
Acebutolol—Hyperhidrosis—Prednisone—systemic scleroderma	0.000348	0.00073	CcSEcCtD
Acebutolol—Vision blurred—Methotrexate—systemic scleroderma	0.000347	0.000728	CcSEcCtD
Acebutolol—Anorexia—Prednisone—systemic scleroderma	0.000343	0.000719	CcSEcCtD
Acebutolol—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000342	0.000717	CcSEcCtD
Acebutolol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000338	0.000708	CcSEcCtD
Acebutolol—Rash—Mycophenolate mofetil—systemic scleroderma	0.000335	0.000702	CcSEcCtD
Acebutolol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000335	0.000701	CcSEcCtD
Acebutolol—Headache—Mycophenolate mofetil—systemic scleroderma	0.000333	0.000697	CcSEcCtD
Acebutolol—Malaise—Methotrexate—systemic scleroderma	0.000332	0.000697	CcSEcCtD
Acebutolol—Vertigo—Methotrexate—systemic scleroderma	0.000331	0.000694	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000328	0.000688	CcSEcCtD
Acebutolol—Insomnia—Prednisone—systemic scleroderma	0.000326	0.000683	CcSEcCtD
Acebutolol—Paraesthesia—Prednisone—systemic scleroderma	0.000323	0.000678	CcSEcCtD
Acebutolol—Cough—Methotrexate—systemic scleroderma	0.000322	0.000674	CcSEcCtD
Acebutolol—Dyspepsia—Prednisone—systemic scleroderma	0.000317	0.000664	CcSEcCtD
Acebutolol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000315	0.000661	CcSEcCtD
Acebutolol—Chest pain—Methotrexate—systemic scleroderma	0.000314	0.000658	CcSEcCtD
Acebutolol—Arthralgia—Methotrexate—systemic scleroderma	0.000314	0.000658	CcSEcCtD
Acebutolol—Myalgia—Methotrexate—systemic scleroderma	0.000314	0.000658	CcSEcCtD
Acebutolol—Decreased appetite—Prednisone—systemic scleroderma	0.000313	0.000656	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000312	0.000653	CcSEcCtD
Acebutolol—Fatigue—Prednisone—systemic scleroderma	0.00031	0.000651	CcSEcCtD
Acebutolol—Discomfort—Methotrexate—systemic scleroderma	0.00031	0.00065	CcSEcCtD
Acebutolol—Constipation—Prednisone—systemic scleroderma	0.000308	0.000645	CcSEcCtD
Acebutolol—Confusional state—Methotrexate—systemic scleroderma	0.000303	0.000636	CcSEcCtD
Acebutolol—Feeling abnormal—Prednisone—systemic scleroderma	0.000297	0.000622	CcSEcCtD
Acebutolol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000295	0.000619	CcSEcCtD
Acebutolol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000294	0.000617	CcSEcCtD
Acebutolol—Skin disorder—Methotrexate—systemic scleroderma	0.000292	0.000613	CcSEcCtD
Acebutolol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000291	0.00061	CcSEcCtD
Acebutolol—Anorexia—Methotrexate—systemic scleroderma	0.000287	0.000601	CcSEcCtD
Acebutolol—Urticaria—Prednisone—systemic scleroderma	0.000286	0.0006	CcSEcCtD
Acebutolol—Body temperature increased—Prednisone—systemic scleroderma	0.000285	0.000597	CcSEcCtD
Acebutolol—Abdominal pain—Prednisone—systemic scleroderma	0.000285	0.000597	CcSEcCtD
Acebutolol—Hypotension—Methotrexate—systemic scleroderma	0.000281	0.000589	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000274	0.000575	CcSEcCtD
Acebutolol—Insomnia—Methotrexate—systemic scleroderma	0.000272	0.00057	CcSEcCtD
Acebutolol—Paraesthesia—Methotrexate—systemic scleroderma	0.00027	0.000566	CcSEcCtD
Acebutolol—Dyspnoea—Methotrexate—systemic scleroderma	0.000268	0.000562	CcSEcCtD
Acebutolol—Somnolence—Methotrexate—systemic scleroderma	0.000267	0.000561	CcSEcCtD
Acebutolol—Dyspepsia—Methotrexate—systemic scleroderma	0.000265	0.000555	CcSEcCtD
Acebutolol—Decreased appetite—Methotrexate—systemic scleroderma	0.000262	0.000548	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00026	0.000545	CcSEcCtD
Acebutolol—Fatigue—Methotrexate—systemic scleroderma	0.000259	0.000544	CcSEcCtD
Acebutolol—Asthenia—Prednisone—systemic scleroderma	0.000258	0.000541	CcSEcCtD
Acebutolol—Pain—Methotrexate—systemic scleroderma	0.000257	0.000539	CcSEcCtD
Acebutolol—Pruritus—Prednisone—systemic scleroderma	0.000255	0.000534	CcSEcCtD
Acebutolol—Feeling abnormal—Methotrexate—systemic scleroderma	0.000248	0.00052	CcSEcCtD
Acebutolol—Diarrhoea—Prednisone—systemic scleroderma	0.000246	0.000516	CcSEcCtD
Acebutolol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000246	0.000516	CcSEcCtD
Acebutolol—Urticaria—Methotrexate—systemic scleroderma	0.000239	0.000501	CcSEcCtD
Acebutolol—Dizziness—Prednisone—systemic scleroderma	0.000238	0.000499	CcSEcCtD
Acebutolol—Abdominal pain—Methotrexate—systemic scleroderma	0.000238	0.000499	CcSEcCtD
Acebutolol—Body temperature increased—Methotrexate—systemic scleroderma	0.000238	0.000499	CcSEcCtD
Acebutolol—Vomiting—Prednisone—systemic scleroderma	0.000229	0.00048	CcSEcCtD
Acebutolol—Rash—Prednisone—systemic scleroderma	0.000227	0.000476	CcSEcCtD
Acebutolol—Dermatitis—Prednisone—systemic scleroderma	0.000227	0.000475	CcSEcCtD
Acebutolol—Headache—Prednisone—systemic scleroderma	0.000226	0.000473	CcSEcCtD
Acebutolol—Asthenia—Methotrexate—systemic scleroderma	0.000216	0.000453	CcSEcCtD
Acebutolol—Nausea—Prednisone—systemic scleroderma	0.000214	0.000448	CcSEcCtD
Acebutolol—Pruritus—Methotrexate—systemic scleroderma	0.000213	0.000446	CcSEcCtD
Acebutolol—Diarrhoea—Methotrexate—systemic scleroderma	0.000206	0.000432	CcSEcCtD
Acebutolol—Dizziness—Methotrexate—systemic scleroderma	0.000199	0.000417	CcSEcCtD
Acebutolol—Vomiting—Methotrexate—systemic scleroderma	0.000191	0.000401	CcSEcCtD
Acebutolol—Rash—Methotrexate—systemic scleroderma	0.00019	0.000398	CcSEcCtD
Acebutolol—Dermatitis—Methotrexate—systemic scleroderma	0.00019	0.000397	CcSEcCtD
Acebutolol—Headache—Methotrexate—systemic scleroderma	0.000188	0.000395	CcSEcCtD
Acebutolol—Nausea—Methotrexate—systemic scleroderma	0.000179	0.000375	CcSEcCtD
